AstraZeneca PLC Pink Sheet Forecast - Triple Exponential Smoothing

AZNCF Stock  USD 131.47  2.46  1.84%   
The Triple Exponential Smoothing forecasted value of AstraZeneca PLC on the next trading day is expected to be 131.07 with a mean absolute deviation of 2.76 and the sum of the absolute errors of 165.56. AstraZeneca Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of AstraZeneca PLC's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Triple exponential smoothing for AstraZeneca PLC - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When AstraZeneca PLC prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in AstraZeneca PLC price movement. However, neither of these exponential smoothing models address any seasonality of AstraZeneca PLC.

AstraZeneca PLC Triple Exponential Smoothing Price Forecast For the 27th of November

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of AstraZeneca PLC on the next trading day is expected to be 131.07 with a mean absolute deviation of 2.76, mean absolute percentage error of 13.12, and the sum of the absolute errors of 165.56.
Please note that although there have been many attempts to predict AstraZeneca Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that AstraZeneca PLC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

AstraZeneca PLC Pink Sheet Forecast Pattern

Backtest AstraZeneca PLCAstraZeneca PLC Price PredictionBuy or Sell Advice 

AstraZeneca PLC Forecasted Value

In the context of forecasting AstraZeneca PLC's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. AstraZeneca PLC's downside and upside margins for the forecasting period are 128.71 and 133.44, respectively. We have considered AstraZeneca PLC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
131.47
128.71
Downside
131.07
Expected Value
133.44
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of AstraZeneca PLC pink sheet data series using in forecasting. Note that when a statistical model is used to represent AstraZeneca PLC pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.5237
MADMean absolute deviation2.7594
MAPEMean absolute percentage error0.0187
SAESum of the absolute errors165.5641
As with simple exponential smoothing, in triple exponential smoothing models past AstraZeneca PLC observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older AstraZeneca PLC observations.

Predictive Modules for AstraZeneca PLC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AstraZeneca PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
129.11131.47133.83
Details
Intrinsic
Valuation
LowRealHigh
115.79118.15144.62
Details
Bollinger
Band Projection (param)
LowMiddleHigh
123.00128.17133.33
Details

Other Forecasting Options for AstraZeneca PLC

For every potential investor in AstraZeneca, whether a beginner or expert, AstraZeneca PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AstraZeneca Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AstraZeneca. Basic forecasting techniques help filter out the noise by identifying AstraZeneca PLC's price trends.

AstraZeneca PLC Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AstraZeneca PLC pink sheet to make a market-neutral strategy. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

AstraZeneca PLC Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AstraZeneca PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AstraZeneca PLC's current price.

AstraZeneca PLC Market Strength Events

Market strength indicators help investors to evaluate how AstraZeneca PLC pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC pink sheet market strength indicators, traders can identify AstraZeneca PLC entry and exit signals to maximize returns.

AstraZeneca PLC Risk Indicators

The analysis of AstraZeneca PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AstraZeneca PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astrazeneca pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in AstraZeneca Pink Sheet

AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.